Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x100px

Organisation › Details

Sofinnova Digital Medicine fund

	Start	2023-03-28 established
	Group	Sofinnova (Group)
	Industry	Sofinnova Digital Medicine fund
	Industry 2	digital health (healthcare informatics)
	Person	Kliphuis, Edward (Sofinnova Partners 202402 Partner before Amadeus Capital + M Ventures + Kempen & Co)
	Person 2	Turner, Simon (Sofinnova 202303 Partner at Sofinnova Partners)

	Region	Paris
	Country	France
	City	n. a.
		Address record changed: 2023-03-30

Basic data	Employees	n. a.


		Record changed: 2024-02-12

More documents for Sofinnova (Group)

[1] Purespring Therapeutics Ltd.. (10/9/24). "Press Release: Purespring Therapeutics Raises £80/$105 Million in a Series B Financing to Transform the Treatment of Kidney Diseases". London....
[2] Genespire S.r.l.. (9/25/24). "Press Release: Genespire Raises €46.6 Million (~$52 Million) in a Series B Round to Advance Its First Pediatric in-vivo Gene Therapy into the Clinic". Milan....
[3] Novameat Tech SL. (9/12/24). "Press Release: Novameat Raises €17.4M Oversubscribed Series A Round Led by Sofinnova Partners and Forbion". Barcelona....
[4] Sofinnova Partners. (9/10/24). "Press Release: Sofinnova Partners Appoints Karl Naegler as Partner". Paris....
[5] Deepc GmbH. (7/24/24). "Press Release: Deepc Closes Series A Extension to Accelerate Global Deployment of Healthcare AI, Bringing Total Funding to $30m". Munich....
[6] Endoron Medical Ltd.. (7/9/24). "Press Release: Endoron Medical Raises $10 Million in Series A Funding Led by Sofinnova Partners to Accelerate the Validation of Its AAA EndoStapling Solution Aortoseal". Tel Aviv....
[7] Marea Therapeutics. (6/18/24). "Press Release: Marea Therapeutics Launches with $190 Million to Accelerate a New Generation of Medicines for Cardiometabolic Diseases". South San Francisco, CA....
[8] Cure51 SAS. (3/20/24). "Press Release: Cure51 Raises a €15 Million Seed Round to Harness the Natural Power of Cancer Survivors to Develop First-in-Class Treatments and Transform Cancer into a Curable Disease". Paris....
[9] Bioptimus SAS. (2/20/24). "Press Release: Ex-Google DeepMind and Owkin Scientists Team up to Create Bioptimus to Build the First Universal AI Foundation Model for Biology"....
[10] GenSight Biologics S.A.. (2/8/24). "Press Release: GenSight Biologics Announces Completion of a €5 million capital Increase with Sofinnova Partners, Invus, UPMC Enterprises and Heights Capital". Paris....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]